Ceftriaxone Sodium NDC 0409-7333

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-7333Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-7333Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-7333-04	00409733304	10 VIAL, SINGLE-USE in 1 CARTON (0409-7333-04) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-7333-11)Marketed from Jul 20, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ceftriaxone Sodium
Generic name (nonproprietary): ceftriaxone sodium
Active ingredients: Ceftriaxone sodium — 1 g/1
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: Hospira, Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065204
Marketing start: Jul 20, 2005
Marketing end: Apr 30, 2027
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 0409-7333_8e4ee031-a0df-403f-8a7e-de9626a7e501SPL ID 8e4ee031-a0df-403f-8a7e-de9626a7e501SPL set ID 128bb292-d174-4769-b3e6-9f16617f31e3RxCUI 1665021, 1665046UNII 023Z5BR09K
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J0696 — Injection, ceftriaxone sodium, per 250 mg

Billing unit: 250 mg. Units on the claim = dose given ÷ 250 mg.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409733304 followed by a unit qualifier and the quantity

Package 00409-7333-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Before instituting treatment with ceftriaxone for injection, USP, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, USP and other antibacterial drugs, ceftriaxone for injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065204

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065204
Product	Strength	Form · route	Labeler	Product NDC
Ceftriaxone Sodium	Ceftriaxone sodium 2 g/1	Injection, Powder, For solutionIntravenous	Hospira, Inc	0409-7336